The Healthcare Hub

GHX provides a wide range of perspectives on how greater collaboration and visibility across the supply chain can improve both clinical and financial performance in healthcare.

Wednesday, August 10, 2022

WATCH ON-DEMAND: Navigating New Product Introductions in a Turbulent Era

With supply costs rising upwards of 20 percent since 2019, having an effective product evaluation process in place at your health system is more critical than ever. During this conversation, GHX Lumere’s Erinn Zacharias, Ph.D., and Suzanne Smith, BSN, RN, highlight the most important considerations for evaluating and approving new medical devices, particularly when a quick decision is needed.


Drawing on decades of research and value analysis experience, Erinn and Suzanne also discuss how evidence can act as the common language in conversations with vendors, colleagues and clinicians, underscoring the importance of access to unbiased research.

Learning Objectives

  • Learn how having an evidence-backed evaluation process can enhance your conversations with vendors, colleagues and clinicians
  • Become proficient in expediting new product introductions without impacting staff and patient safety or care quality
  • Know what NOT to skip when evaluating new medical devices